HIK.L - Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC
JPMorganEstimate Decrease, Price Target Decrease

Hikma Pharmaceuticals Patience and execution required to restore confidence in achievability of at least MSD Sales growth through the mid-term for which current levels are undemanding

公司
HIK.L
日期
2026-03-03
分析师
Zain Ebrahim
页数
12 页
需要登录
请登录后购买研报或生成音频内容。